Exelixis Clinical Site #21 — New Haven, Connecticut

Exelixis Clinical Site #21 is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Exelixis Clinical Site #21 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Differentiated Thyroid Cancer.

Sponsors: Exelixis.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Haven

Browse all research sites in Connecticut · View every site in New Haven

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Exelixis Clinical Site #21?

Exelixis Clinical Site #21 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Exelixis Clinical Site #21 conducted?

Exelixis Clinical Site #21 has 1 clinical trials on record, with 1 currently active. Their work covers Differentiated Thyroid Cancer.

Is Exelixis Clinical Site #21 accredited by Crixeo Clinical Trials?

Exelixis Clinical Site #21 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Exelixis Clinical Site #21?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.